Canal Insurance CO Abb Vie Inc. Call Options Transaction History

Canal Insurance CO

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Oct 30, 2024	BUY	$163.84 - $199.33 $24,576 - $29,899	150 New	150 $204,000
Q1 2023 Apr 27, 2023	SELL	$144.61 - $166.54 $3,615 - $4,163	-25 Reduced 10.0%	225 $153,000
Q4 2022 Feb 01, 2023	BUY	$138.31 - $165.87 $34,577 - $41,467	250 New	250 $440,000
Q1 2022 Apr 22, 2022	SELL	$131.98 - $163.75 $13,197 - $16,375	-100 Reduced 50.0%	100 $105,000
Q1 2021 Apr 20, 2021	SELL	$102.3 - $112.62 $2.03 Million - $2.23 Million	-19,800 Reduced 99.0%	200 $21,000
Q2 2020 Aug 04, 2020	SELL	$73.37 - $98.18 $733,700 - $981,800	-10,000 Reduced 33.33%	20,000 $1.96 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $2.67 Million - $2.97 Million	30,000 New	30,000 $44,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Canal Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Canal Insurance CO with notifications on news.